Healthcare provider profile · identity verified

Jeffrey A Demoss, DO

Family Practice · TUCSON, AZ · NPI 1568487841

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	458	197
Losartan Potassium	Losartan Potassium	350	149
Levothyroxine Sodium	Levothyroxine Sodium	340	141
Amlodipine Besylate	Amlodipine Besylate	305	144
Rosuvastatin Calcium	Rosuvastatin Calcium	258	116
Lisinopril	Lisinopril	245	105
Metformin Hcl	Metformin Hcl	221	92
Jardiance	Empagliflozin	176	63
Pantoprazole Sodium	Pantoprazole Sodium	149	71
Gabapentin	Gabapentin	148	83
Hydrochlorothiazide	Hydrochlorothiazide	133	62
Omeprazole	Omeprazole	124	55
Tamsulosin Hcl	Tamsulosin Hcl	115	55
Carvedilol	Carvedilol	114	44
Pioglitazone Hcl	Pioglitazone Hcl	108	43
Metoprolol Succinate	Metoprolol Succinate	104	48
Trazodone Hcl	Trazodone Hcl	86	38
Albuterol Sulfate Hfa	Albuterol Sulfate	83	35
Metoprolol Tartrate	Metoprolol Tartrate	79	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	29
Meloxicam	Meloxicam	68	31
Alprazolam	Alprazolam	65	29
Furosemide	Furosemide	65	27
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	22
Zolpidem Tartrate	Zolpidem Tartrate	63	23
Prednisone	Prednisone	62	37
Bupropion Xl	Bupropion Hcl	61	27
Eliquis	Apixaban	59	22
Allopurinol	Allopurinol	58	25
Simvastatin	Simvastatin	58	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	25
Trulicity	Dulaglutide	57	27
Pravastatin Sodium	Pravastatin Sodium	56	22
Duloxetine Hcl	Duloxetine Hcl	55	20
Finasteride	Finasteride	54	24
Escitalopram Oxalate	Escitalopram Oxalate	53	27
Clopidogrel	Clopidogrel Bisulfate	52	22
Doxepin Hcl	Doxepin Hcl	49	16
Sertraline Hcl	Sertraline Hcl	48	22
Tramadol Hcl	Tramadol Hcl	48	15
Valsartan	Valsartan	48	19
Metformin Hcl Er	Metformin Hcl	47	25
Montelukast Sodium	Montelukast Sodium	46	22
Fluticasone Propionate	Fluticasone Propionate	44	23
Acyclovir	Acyclovir	42	12
Atenolol	Atenolol	42	16
Fluconazole	Fluconazole	41	25
Ozempic	Semaglutide	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	20
Mounjaro	Tirzepatide	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	16
Azithromycin	Azithromycin	36	30
Paroxetine Hcl	Paroxetine Hcl	35	19
Celecoxib	Celecoxib	34	15
Sildenafil Citrate	Sildenafil Citrate	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	14
Diclofenac Sodium	Diclofenac Sodium	33	11
Symbicort	Budesonide/Formoterol Fumarate	33	17
Alendronate Sodium	Alendronate Sodium	32	13
Ezetimibe	Ezetimibe	32	13
Ibuprofen	Ibuprofen	31	19
Potassium Chloride	Potassium Chloride	30	17
Famotidine	Famotidine	29	16
Pregabalin	Pregabalin	29	14
Aripiprazole	Aripiprazole	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	13
Fenofibrate	Fenofibrate	27	12
Citalopram Hbr	Citalopram Hydrobromide	26	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Methocarbamol	Methocarbamol	25	15
Donepezil Hcl	Donepezil Hcl	24	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	11
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Lovastatin	Lovastatin	23	suppressed
Topiramate	Topiramate	23	11
Fluoxetine Hcl	Fluoxetine Hcl	22	13
Hydroxyzine Hcl	Hydroxyzine Hcl	22	11
Ibu	Ibuprofen	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	12
Raloxifene Hcl	Raloxifene Hcl	22	14
Baclofen	Baclofen	21	suppressed
Estradiol	Estradiol	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Sulindac	Sulindac	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Colchicine	Colchicine	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Glipizide	Glipizide	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Nystatin	Nystatin	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	11
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Naproxen	Naproxen	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error